Julia L Marcus1, Whitney C Sewell2, Laura B Balzer3, Douglas S Krakower4. 1. Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Dr, Ste 401, Boston, MA, 02215, USA. julia_marcus@harvardpilgrim.org. 2. Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Dr, Ste 401, Boston, MA, 02215, USA. 3. University of Massachusetts Amherst, 715 North Pleasant St, Amherst, MA, 01003, USA. 4. Beth Israel Deaconess Medical Center, Division of Infectious Diseases, 110 Francis St., W/LMOB Suite GB, Boston, MA, 02215, USA.
Abstract
PURPOSE OF REVIEW: We review applications of artificial intelligence (AI), including machine learning (ML), in the field of HIV prevention. RECENT FINDINGS: ML approaches have been used to identify potential candidates for preexposure prophylaxis (PrEP) in healthcare settings in the USA and Denmark and in a population-based research setting in Eastern Africa. Although still in the proof-of-concept stage, other applications include ML with smartphone-collected and social media data to promote real-time HIV risk reduction, virtual reality tools to facilitate HIV serodisclosure, and chatbots for HIV education. ML has also been used for causal inference in HIV prevention studies. ML has strong potential to improve delivery of PrEP, with this approach moving from development to implementation. Development and evaluation of AI and ML strategies for HIV prevention may benefit from an implementation science approach, including qualitative assessments with end users, and should be developed and evaluated with attention to equity.
PURPOSE OF REVIEW: We review applications of artificial intelligence (AI), including machine learning (ML), in the field of HIV prevention. RECENT FINDINGS: ML approaches have been used to identify potential candidates for preexposure prophylaxis (PrEP) in healthcare settings in the USA and Denmark and in a population-based research setting in Eastern Africa. Although still in the proof-of-concept stage, other applications include ML with smartphone-collected and social media data to promote real-time HIV risk reduction, virtual reality tools to facilitate HIV serodisclosure, and chatbots for HIV education. ML has also been used for causal inference in HIV prevention studies. ML has strong potential to improve delivery of PrEP, with this approach moving from development to implementation. Development and evaluation of AI and ML strategies for HIV prevention may benefit from an implementation science approach, including qualitative assessments with end users, and should be developed and evaluated with attention to equity.
Entities:
Keywords:
Artificial intelligence; Big data; Data science; Human immunodeficiency virus (HIV); Machine learning; Prevention
Authors: Jeb Jones; Martin Hoenigl; Aaron J Siegler; Patrick S Sullivan; Susan Little; Eli Rosenberg Journal: Sex Transm Dis Date: 2017-05 Impact factor: 2.830
Authors: Douglas K Owens; Karina W Davidson; Alex H Krist; Michael J Barry; Michael Cabana; Aaron B Caughey; Susan J Curry; Chyke A Doubeni; John W Epling; Martha Kubik; C Seth Landefeld; Carol M Mangione; Lori Pbert; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong Journal: JAMA Date: 2019-06-11 Impact factor: 56.272
Authors: Catherine A Koss; James Ayieko; Florence Mwangwa; Asiphas Owaraganise; Dalsone Kwarisiima; Laura B Balzer; Albert Plenty; Norton Sang; Jane Kabami; Theodore D Ruel; Douglas Black; Carol S Camlin; Craig R Cohen; Elizabeth A Bukusi; Tamara D Clark; Edwin D Charlebois; Maya L Petersen; Moses R Kamya; Diane V Havlir Journal: Clin Infect Dis Date: 2018-11-28 Impact factor: 9.079
Authors: Gabriel Chamie; Tamara D Clark; Jane Kabami; Kevin Kadede; Emmanuel Ssemmondo; Rachel Steinfeld; Geoff Lavoy; Dalsone Kwarisiima; Norton Sang; Vivek Jain; Harsha Thirumurthy; Teri Liegler; Laura B Balzer; Maya L Petersen; Craig R Cohen; Elizabeth A Bukusi; Moses R Kamya; Diane V Havlir; Edwin D Charlebois Journal: Lancet HIV Date: 2016-01-26 Impact factor: 12.767
Authors: Jessica P Ridgway; Eleanor E Friedman; Alvie Bender; Jessica Schmitt; Michael Cronin; Rayna N Brown; Amy K Johnson; Lisa R Hirschhorn Journal: AIDS Patient Care STDS Date: 2021-01 Impact factor: 5.078
Authors: Katherine M Jia; Hallie Eilerts; Olanrewaju Edun; Kevin Lam; Adam Howes; Matthew L Thomas; Jeffrey W Eaton Journal: J Int AIDS Soc Date: 2022-01 Impact factor: 5.396
Authors: Xianglong Xu; Zongyuan Ge; Eric P F Chow; Zhen Yu; David Lee; Jinrong Wu; Jason J Ong; Christopher K Fairley; Lei Zhang Journal: J Clin Med Date: 2022-03-25 Impact factor: 4.241
Authors: Charles K Mutai; Patrick E McSharry; Innocent Ngaruye; Edouard Musabanganji Journal: BMC Med Res Methodol Date: 2021-07-31 Impact factor: 4.615